Procurement Summary
Country: Ukraine
Summary: Suxamethonium, Solution for Injection, 20 Mg/Ml, 5 Ml Each; Oxytocin, Solution for Injection 5 Iu/Ml; Valproic Acid, Tablets, 500 Mg Each; Hydrochlorothiazide 25 Mg Tablets; Hydroxyethyl Starch (Average M...
Deadline: 02 Jun 2026
Posting Date: 30 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 142332823
Document Ref. No.: UA-2026-05-28-011088-a
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: UAH 880000
CPV Classification
33600000 - Pharmaceutical products
33630000 - Medicinal products for dermatology and the musculo-skeletal system
33640000 - Medicinal products for the genitourinary system and hormones
33660000 - Medicinal products for the nervous system and sensory organs
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Suxamethonium, solution for injection, 20 mg/ml, 5 ml each; Oxytocin, solution for injection 5 IU/ml; Valproic acid, tablets, 500 mg each; Hydrochlorothiazide 25 mg tablets; Hydroxyethyl starch (average molecular weight 200, 000), 6%, 200 ml each; sodium chloride, solution for infusions, 9 mg/ml 1000 ml; Sodium chloride, solution for infusions, 9 mg/ml 100 ml; Fluconazole, solution for infusions, 2 mg/ml, 100 ml each; Chlorhexidine, solution for external use 0.05% per 100 ml; Ondansetron solution for injection 2 mg/ml in 4 ml; Ceftriaxone, powder for injections of 1 g; Levofloxacin solution for infusions, 5 mg/ml, 100 ml; Paracetamol solution for infusions 10 mg/ml 100 ml; Caspofungin powder for concentrate for solution for infusion 50 mg, bottle Type of purchase: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Classification according to ATX: D08AC02, INN: Chlorhexidine, Release form: Solution for external use, Dose of active substance: 0.05%, Volume: 100 ml, Packaging type: Vial; Ondansetron solution for injections of 2 mg/ml by 4 ml; Caspofungin: Classification according to INN: Caspofungin, Classification according to ATC: J02AX04, Release form: Powder for concentrate for solution for infusion, Dose of active ingredient: 50 mg, Type of packaging: Vial Classifier and its name corresponding code Quantity/Measurement units Place of delivery Date of delivery Name DK 021:2015: 33600000-6 — Pharmaceutical products Classification according to ATX: D08AC02, INN: Chlorhexidine, Release form: Solution for external use, Dose of active substance: 0.05 %, Volume: 100 ml, Packaging type: Bottle; Ondansetron solution for injection 2 mg/ml in 4 ml; Caspofungin: Classification according to INN: Caspofungin, Classification according to ATX: J02AX04, Release form: Powder for concentrate for solution for infusion, Effective dose substances: 50 mg, Type of packaging: Vial Name Classifier and its corresponding code Quantity/Units of measu...
Documents
Tender Notice